Identification of LAT4, a novel amino acid transporter with system L activity

Identification of LAT4, a novel amino acid transporter with system L activity

Item
http://www.wikidata.org/entity/Q28513311
Molecular pathogenesis of megalencephalic leukoencephalopathy with subcortical cysts: mutations in MLC1 cause folding defectsAmino acid transporter LAT3 is required for podocyte development and functionPharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentinQuantifying the relative contributions of different solute carriers to aggregate substrate transportNon-physiological amino acid (NPAA) therapy targeting brain phenylalanine reduction: pilot studies in PAHENU2 miceThe Concise Guide to PHARMACOLOGY 2013/14: transporters.The actions of exogenous leucine on mTOR signalling and amino acid transporters in human myotubes.Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle.Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancerMonoterpene glycoside ESK246 from Pittosporum targets LAT3 amino acid transport and prostate cancer cell growth.A transcriptome analysis by lasso penalized Cox regression for pancreatic cancer survival.Homocysteine is transported by the microvillous plasma membrane of human placentaComparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors.Tumor necrosis factor-α suppresses the protein fractional synthesis rate of the small intestine stimulated by glutamine in rats.Placental adaptations in growth restriction.Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma.Identification of radiation-induced aberrant hypomethylation in colon cancer.Amino acid export in plants: a missing link in nitrogen cyclingTryptophan transport in human fibroblast cells-a functional characterization.The mTORC1/4E-BP pathway coordinates hemoglobin production with L-leucine availability.L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia.Physiological Competition of Brain Phenylalanine Accretion: Initial Pharmacokinetic Analyses of Aminoisobutyric and Methylaminoisobutyric Acids in Pah(enu2-/-) Mice.Analysis of L-type amino acid transporter in canine hepatocellular carcinoma.Molecular basis of essential amino acid transport from studies of insect nutrient amino acid transporters of the SLC6 family (NAT-SLC6)Functional identification of SLC43A3 as an equilibrative nucleobase transporter involved in purine salvage in mammals.Transporters for uptake and allocation of organic nitrogen compounds in plants.The methylmercury-L-cysteine conjugate is a substrate for the L-type large neutral amino acid transporterL-methionine placental uptake: characterization and modulation in gestational diabetes mellitusThe functional and molecular entities underlying amino acid and peptide transport by the mammary gland under different physiological and pathological conditions.Transport of amino acids in the kidney.Effect of heat stress on amino acid digestibility and transporters in meat-type chickens.Glycosylation of solute carriers: mechanisms and functional consequences.Reconstitution of T Cell Proliferation under Arginine Limitation: Activated Human T Cells Take Up Citrulline via L-Type Amino Acid Transporter 1 and Use It to Regenerate Arginine after Induction of Argininosuccinate Synthase Expression.LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines.Gastrointestinal methionine shuttle: Priority handling of precious goods.Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment.The involvement of L-type amino acid transporters in theanine transport.Synthesis, uptake mechanism characterization and biological evaluation of (18)F labeled fluoroalkyl phenylalanine analogs as potential PET imaging agents.Analysis and update of the human solute carrier (SLC) gene superfamily
P2860
Q24642920-DF006A67-60B4-4080-84E1-94FED33C6A44Q24649770-D5869CB6-2223-482A-980D-410FCE4CDD8AQ24656027-01ADE9F2-C67E-4A0A-B774-101877CDF25BQ28468327-09686D18-0A94-4A51-9A9E-21D29D78A2C6Q28703649-58550B84-B9E5-4B01-A3A7-4896627A4D42Q30486743-0C50081C-7344-46CC-9041-77AF2F63D870Q31021169-1400F9C1-93E1-42F7-9C61-BA1FBA69438FQ33300420-B80BCF00-BC9C-4E8F-A329-4B217C5E39AFQ33592952-FCA6CB6F-FA75-4DF4-B4AD-250E2FBA20FEQ33797210-988BA01A-B9DF-49AE-A0BE-8E1C54318013Q34238554-8B8F4928-656D-4CEF-9414-6F632718AD81Q34253323-F56894AD-E35E-4ECB-BF45-D5209EB2E38BQ34348544-729B4CBA-4A14-49AE-BCCE-BC131C2917F1Q34795654-9D4EA68C-589A-4392-9D6E-6EAAAAA852ACQ35003807-BAE4A2BE-29C0-4894-A491-0CCAB84E8BA5Q35028079-C8930149-39EA-40A5-A9CB-A32E9CEC1E80Q35127773-6C2B6A9C-7B1B-4944-AEB7-8D9008BCDA34Q35128536-890300DF-2035-41B5-941E-DA3D13EE380CQ35366684-6D6245CC-3808-4E62-8CDA-07F9512BF5DCQ35478977-CD72089E-706C-44DE-98F1-03640F0C8F28Q35757977-5553F163-4220-4310-99EF-6D7F59A763E3Q35774242-0501B03D-CABA-4692-85EC-5AB394C9FD9AQ35774573-956CEE68-9E9A-4A00-A678-359C2BDE0286Q36096856-B6313A2F-AF62-4681-9E4F-F5943958241EQ36699713-B291A3D2-AF80-409E-8B49-E0B87C0D4DA9Q36805342-F4D32CF3-8F1B-4C6B-9BAE-C44745310A18Q36968631-43E39F63-B028-4086-9271-2450CD7F4E72Q37280143-3E2E57D0-EEF4-4DD1-9D06-0053E6E40F99Q38155424-71633D75-5F3E-4852-8AED-31291E68D353Q38201388-58BCD554-7AD6-4906-8BEC-482E72B818C4Q38405085-7C6235D0-87B0-4773-B211-FD9A27CC624EQ38588958-805991FC-4430-4964-9685-CD3C435C2C74Q38633026-304DF74B-01F2-4D01-9B3F-3270C71372BEQ38754089-E6A75E24-B1A7-421A-9FE2-82154AF70B9DQ38977050-391A2BA2-7666-423B-B121-0FD56DE1978BQ38983691-AF85105C-896E-4306-87F4-712501548F9EQ39112756-12B41713-5088-4F38-B011-7AA7E4AC8A07Q39230333-2BA3A21A-B804-48E6-91BE-B37702A350DAQ39609869-C2B0A344-9938-4F2A-B5CC-09321A300249Q41857194-42789A7D-21F4-4185-91FA-17DB8A13F463
P2860

Identification of LAT4, a novel amino acid transporter with system L activity

Item
http://www.wikidata.org/entity/Q28513311
description
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 2005
@ast
im März 2005 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2005/03/25)
@sk
vědecký článek publikovaný v roce 2005
@cs
wetenschappelijk artikel (gepubliceerd op 2005/03/25)
@nl
наукова стаття, опублікована в березні 2005
@uk
name
Identification of LAT4, a novel amino acid transporter with system L activity
@ast
Identification of LAT4, a novel amino acid transporter with system L activity
@en
Identification of LAT4, a novel amino acid transporter with system L activity
@nl
type
label
Identification of LAT4, a novel amino acid transporter with system L activity
@ast
Identification of LAT4, a novel amino acid transporter with system L activity
@en
Identification of LAT4, a novel amino acid transporter with system L activity
@nl
prefLabel
Identification of LAT4, a novel amino acid transporter with system L activity
@ast
Identification of LAT4, a novel amino acid transporter with system L activity
@en
Identification of LAT4, a novel amino acid transporter with system L activity
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Identification of LAT4, a novel amino acid transporter with system L activity
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921